Opthea
Biopharmaceutical company developing novel therapies for retinal diseases including wet age-related macular degeneration using VEGF-C/VEGF-D pathway inhibitors.
About
What Opthea is
Biopharmaceutical company developing novel therapies for retinal diseases including wet age-related macular degeneration using VEGF-C/VEGF-D pathway inhibitors.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://opthea.com |
| Status coverage | Public status page |
| Founded | 2006 |
| Headquarters | Melbourne, Victoria, Australia |
| Categories | Enterprise, Healthcare |
Loading offerings...